COVID-19 Vaccine ‘Possibly’ Linked to Rare Blood Clots: EU Agency

by akoloy

The European Union’s drug regulation company on Wednesday mentioned there’s a “possible link” between the AstraZeneca CCP virus vaccine and “very rare” blood clots however beneficial that vaccinations proceed and confused the advantages outweigh the dangers.

The European Medicines Agency (EMA) “is reminding healthcare professionals and people receiving the vaccine to remain aware of the possibility of very rare cases of blood clots combined with low levels of blood platelets occurring within 2 weeks of vaccination,” the company said in a statement Wednesday.

The assertion continued: “So far, most of the cases reported have occurred in women under 60 years of age within 2 weeks of vaccination. Based on the currently available evidence, specific risk factors have not been confirmed.”

The Epoch Times has contacted AstraZeneca for remark. The pharmaceutical large and the World Health Organization (WHO) have beforehand said that its research have discovered no larger threat of clots as a result of vaccine.

EMA officers reviewed a number of dozen instances that got here primarily from Europe and the United Kingdom, the place round 25 million folks have obtained the AstraZeneca vaccine, in line with EMA’s assertion.

“The reported cases of unusual blood clotting following vaccination with the AstraZeneca vaccine should be listed as possible side effects of the vaccine,” mentioned Emer Cooke, the company’s govt director, to reporters. “The risk of mortality from COVID is much greater than the risk of mortality from these side effects,” Cooke mentioned.

Last month, greater than a dozen European nations—together with France, Germany, Italy, and Spain—suspended utilization of the AstraZeneca vaccine following reviews of blood clots in addition to a number of deaths in individuals who had obtained the shot. Most nations have resumed utilizing the vaccine however some have suspended inoculations in older people.

The doable causes of the blood clot are nonetheless not absolutely identified, mentioned Marco Cavaleri, chair of the vaccine analysis crew on the EMA.

“In my opinion, we can now say it, it is clear that there is an association with the vaccine. However, we still do not know what causes this reaction,” he told Italian media.

On Tuesday, AstraZeneca and Oxford University, which developed the vaccine, paused a examine of the shot in kids whereas the UK regulator evaluates the hyperlink between the shot and uncommon blood clots in adults.

Officials in Spain’s Castilla y León area additionally suspended utilization of the vaccine. Local well being chief Veronica Casado mentioned Wednesday that “the principle of prudence” drove her to place a brief maintain on the vaccine that she nonetheless backed as being each efficient and needed, reported AP.

“If there are in fact individuals of a certain age group that could have a higher risk (of clotting) then we need to adjust its use,” Casado mentioned. “We are not questioning AstraZeneca. We need all the vaccines possible to reach the goal of 70 percent of the adult population.”

The Associated Press contributed to this report.

From The Epoch Times

Source link

You may also like

Leave a Reply

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

We are happy to introduce our Youtube Channel

Subscribe to get curated news from various unbias news channels
Share via
Copy link
Powered by Social Snap